These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 35126852)

  • 1. Can the computed tomography texture analysis of colorectal liver metastases predict the response to first-line cytotoxic chemotherapy?
    Rabe E; Cioni D; Baglietto L; Fornili M; Gabelloni M; Neri E
    World J Hepatol; 2022 Jan; 14(1):244-259. PubMed ID: 35126852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR texture analysis: potential imaging biomarker for predicting the chemotherapeutic response of patients with colorectal liver metastases.
    Zhang H; Li W; Hu F; Sun Y; Hu T; Tong T
    Abdom Radiol (NY); 2019 Jan; 44(1):65-71. PubMed ID: 29967982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT texture analysis in colorectal liver metastases: A better way than size and volume measurements to assess response to chemotherapy?
    Rao SX; Lambregts DM; Schnerr RS; Beckers RC; Maas M; Albarello F; Riedl RG; Dejong CH; Martens MH; Heijnen LA; Backes WH; Beets GL; Zeng MS; Beets-Tan RG
    United European Gastroenterol J; 2016 Apr; 4(2):257-63. PubMed ID: 27087955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Histopathologic Growth Patterns of Colorectal Liver Metastases with a Noninvasive Imaging Method.
    Cheng J; Wei J; Tong T; Sheng W; Zhang Y; Han Y; Gu D; Hong N; Ye Y; Tian J; Wang Y
    Ann Surg Oncol; 2019 Dec; 26(13):4587-4598. PubMed ID: 31605342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapy.
    Ravanelli M; Agazzi GM; Tononcelli E; Roca E; Cabassa P; Baiocchi G; Berruti A; Maroldi R; Farina D
    Radiol Med; 2019 Sep; 124(9):877-886. PubMed ID: 31172448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deep learning-based radiomics predicts response to chemotherapy in colorectal liver metastases.
    Wei J; Cheng J; Gu D; Chai F; Hong N; Wang Y; Tian J
    Med Phys; 2021 Jan; 48(1):513-522. PubMed ID: 33119899
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT texture analysis in colorectal liver metastases and the surrounding liver parenchyma and its potential as an imaging biomarker of disease aggressiveness, response and survival.
    Beckers RCJ; Trebeschi S; Maas M; Schnerr RS; Sijmons JML; Beets GL; Houwers JB; Beets-Tan RGH; Lambregts DMJ
    Eur J Radiol; 2018 May; 102():15-21. PubMed ID: 29685529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrast-enhanced ultrasound can guide the therapeutic strategy by improving the detection of colorectal liver metastases.
    Sawatzki M; Güller U; Güsewell S; Husarik DB; Semela D; Brand S
    J Hepatol; 2021 Feb; 74(2):419-427. PubMed ID: 33065168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiomics Texture Analysis for the Identification of Colorectal Liver Metastases Sensitive to First-Line Oxaliplatin-Based Chemotherapy.
    Nakanishi R; Oki E; Hasuda H; Sano E; Miyashita Y; Sakai A; Koga N; Kuriyama N; Nonaka K; Fujimoto Y; Jogo T; Hokonohara K; Hu Q; Hisamatsu Y; Ando K; Kimura Y; Yoshizumi T; Mori M
    Ann Surg Oncol; 2021 Jun; 28(6):2975-2985. PubMed ID: 33454878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of transformation in the histopathological growth pattern of colorectal liver metastases after chemotherapy using CT-based radiomics.
    Wei S; Gou X; Zhang Y; Cui J; Liu X; Hong N; Sheng W; Cheng J; Wang Y
    Clin Exp Metastasis; 2024 Apr; 41(2):143-154. PubMed ID: 38416301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis.
    Ahn SJ; Kim JH; Park SJ; Han JK
    Eur J Radiol; 2016 Oct; 85(10):1867-1874. PubMed ID: 27666629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiomics diagnosed histopathological growth pattern in prediction of response and 1-year progression free survival for colorectal liver metastases patients treated with bevacizumab containing chemotherapy.
    Wei S; Han Y; Zeng H; Ye S; Cheng J; Chai F; Wei J; Zhang J; Hong N; Bao Y; Zhou J; Ye Y; Meng X; Zhou Y; Deng Y; Qiu M; Tian J; Wang Y
    Eur J Radiol; 2021 Sep; 142():109863. PubMed ID: 34343846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT texture features of liver parenchyma for predicting development of metastatic disease and overall survival in patients with colorectal cancer.
    Lee SJ; Zea R; Kim DH; Lubner MG; Deming DA; Pickhardt PJ
    Eur Radiol; 2018 Apr; 28(4):1520-1528. PubMed ID: 29164382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic radiomics for predicting the efficacy of antiangiogenic therapy in colorectal liver metastases.
    Qu H; Zhai H; Zhang S; Chen W; Zhong H; Cui X
    Front Oncol; 2023; 13():992096. PubMed ID: 36814812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prediction of the therapeutic response after target-combined chemotherapy treatment for patients with liver metastasis from colorectal cancer using computed tomography texture analysis].
    Zhang J; Zhou Y; Qiu M; Wu B
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2018 Dec; 35(6):914-920. PubMed ID: 30583317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CT-based radiomics for the identification of colorectal cancer liver metastases sensitive to first-line irinotecan-based chemotherapy.
    Qi W; Yang J; Zheng L; Lu Y; Liu R; Ju Y; Niu T; Wang D
    Med Phys; 2023 May; 50(5):2705-2714. PubMed ID: 36841949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive diagnostic imaging of colorectal liver metastases.
    Mainenti PP; Romano F; Pizzuti L; Segreto S; Storto G; Mannelli L; Imbriaco M; Camera L; Maurea S
    World J Radiol; 2015 Jul; 7(7):157-69. PubMed ID: 26217455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal Cancer Liver Metastases: Diagnostic Performance and Prognostic Value of PET/MR Imaging.
    Lee DH; Lee JM; Hur BY; Joo I; Yi NJ; Suh KS; Kang KW; Han JK
    Radiology; 2016 Sep; 280(3):782-92. PubMed ID: 27092659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early evaluation using a radiomic signature of unresectable hepatic metastases to predict outcome in patients with colorectal cancer treated with FOLFIRI and bevacizumab.
    Dohan A; Gallix B; Guiu B; Le Malicot K; Reinhold C; Soyer P; Bennouna J; Ghiringhelli F; Barbier E; Boige V; Taieb J; Bouché O; François E; Phelip JM; Borel C; Faroux R; Seitz JF; Jacquot S; Ben Abdelghani M; Khemissa-Akouz F; Genet D; Jouve JL; Rinaldi Y; Desseigne F; Texereau P; Suc E; Lepage C; Aparicio T; Hoeffel C;
    Gut; 2020 Mar; 69(3):531-539. PubMed ID: 31101691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.